Elanco Animal Health (ELAN) Tops Q4 EPS by 6c; Guides FY23

Elanco Animal Health (NYSE: ELAN) reported Q4 EPS of $0.19, $0.06 better than the analyst estimate of $0.13. Revenue for the quarter came in at $988 million versus the consensus estimate of $982.82 million.

GUIDANCE:

Elanco Animal Health sees FY2023 EPS of $0.74-$0.83, versus the consensus of $0.99. Elanco Animal Health sees FY2023 revenue of $4.28-4.4 billion, versus the consensus of $4.39 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.

You May Also Be Interested In

• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• Innovex closes $95M acquisition of TCO Group AS
• Franklin Covey (FC) Misses Q3 EPS by 2c, lowers Guidance